Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting genetically modified macrophages to the glomerulus.

H M Wilson1, D C Kluth

  • 1Department of Medicine and Therapeutics, Institute of Medical Sciences, Foresterhill, Aberdeen, Scotland. d.c.kluth@abdn.ac.uk

Nephron. Experimental Nephrology
|September 16, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Colitis in a transgenic mouse model of autoimmune uveitis may be induced by neoantigen presentation in the bowel.

Scientific reports·2023
Same author

Changes to management of hypertension in pregnancy, and attitudes to self-management: An online survey of obstetricians, before and following the first wave of the COVID-19 pandemic.

Pregnancy hypertension·2021
Same author

Myeloid protein tyrosine phosphatase 1B (PTP1B) deficiency protects against atherosclerotic plaque formation in the ApoE<sup>-/-</sup> mouse model of atherosclerosis with alterations in IL10/AMPKα pathway.

Molecular metabolism·2017
Same author

Comparison of fluorodeoxyglucose uptake in symptomatic carotid artery and stable femoral artery plaques.

The British journal of surgery·2014
Same author

Predominance of activated, clonally expanded T helper type 17 cells within the CD4+ T cell population in psoriatic lesions.

Clinical and experimental immunology·2013
Same author

Macrophage subtypes in symptomatic carotid artery and femoral artery plaques.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2012
Same journal

Inhalation of Hydrogen Gas Is Beneficial for Preventing Contrast-Induced Acute Kidney Injury in Rats.

Nephron. Experimental nephrology·2015
Same journal

Polyuria in Hantavirus Infection Reflects Disease Severity and Is Associated with Prolonged Hospital Stay: A Systematic Analysis of 335 Patients from Southern Germany.

Nephron. Experimental nephrology·2014
Same journal

Stimulation of Cyclooxygenase 2 Expression in Rat Peritoneal Mesothelial Cells.

Nephron. Experimental nephrology·2014
Same journal

Beneficial Effects of AMP-Activated Protein Kinase Agonists in Kidney Ischemia-Reperfusion: Autophagy and Cellular Stress Markers.

Nephron. Experimental nephrology·2014
Same journal

Wnt5a is necessary for normal kidney development in zebrafish and mice.

Nephron. Experimental nephrology·2014
Same journal

Protective effects of relaxin against cisplatin-induced nephrotoxicity in rats.

Nephron. Experimental nephrology·2014
See all related articles

Modified macrophages offer a promising approach for gene therapy in kidney diseases. These cells can be engineered to target inflamed glomeruli, delivering therapeutic genes directly to diseased sites in the kidneys.

Area of Science:

  • Nephrology
  • Immunology
  • Gene Therapy

Background:

  • Macrophages play a critical role in the pathogenesis of most renal diseases.
  • Inflamed glomeruli present a target for localized therapeutic interventions.
  • Macrophages can be utilized as cellular vehicles for targeted delivery.

Purpose of the Study:

  • To review the current strategies for targeting modified macrophages to inflamed glomeruli.
  • To discuss factors influencing macrophage localization and gene transfer.
  • To summarize recent advancements in macrophage-based gene therapy for glomerular diseases.

Main Methods:

  • Ex vivo genetic modification of macrophages using viral vectors.
  • Re-introduction of modified macrophages into the body.

Related Experiment Videos

  • Analysis of macrophage homing to inflamed glomeruli.
  • Review of in vivo gene delivery techniques.

    • Main Results:

    • Macrophages can be effectively engineered for targeted delivery.
    • Factors controlling macrophage localization to glomeruli are being elucidated.
    • Gene therapy using modified macrophages shows potential in preclinical studies for glomerular disease.

    Conclusions:

    • Genetically modified macrophages represent a viable strategy for site-specific gene therapy in renal diseases.
    • Further research is needed to optimize targeting and delivery for clinical application.
    • Macrophage-based gene therapy holds promise for treating glomerular diseases.